Safety and effectiveness of apixaban compared to warfarin in dialysis patients
Author:
Affiliation:
1. Division of Hematology & Oncology; University of Virginia; Charlottesville VA USA
2. Department of Pharmacy; University of Virginia; Charlottesville VA USA
3. Department of Medicine; University of Virginia; Charlottesville VA USA
Publisher
Wiley
Subject
Hematology
Reference35 articles.
1. Venous and arterial thrombosis in dialysis patients;Ocak;Thromb Haemost,2011
2. Chronic dialysis patients have high risk for pulmonary embolism;Tveit;Am J Kidney Dis,2002
3. Chronic kidney disease increases risk for venous thromboembolism;Wattanakit;J Am Soc Nephrol,2008
4. Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the swedish atrial fibrillation cohort study;Friberg;Eur Heart J,2015
5. Clinical characteristics of hemodialysis patients with atrial fibrillation: the RAKUEN (registry of atrial fibrillation in chronic kidney disease under hemodialysis from niigata) study;Mitsuma;J Cardiol,2016
Cited by 86 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Editorial commentary: Oral anticoagulation for hemodialysis patients with atrial fibrillation: The therapeutic conundrum remains;Trends in Cardiovascular Medicine;2024-10
2. Reprint of: Efficacy and safety of apixaban compared to warfarin for nonvalvular atrial fibrillation in end-stage renal disease on hemodialysis;Journal of the American Pharmacists Association;2024-08
3. Direct Oral Anticoagulants Exhibit Lower Risks of Mortality and Bleeding Compared to Vitamin K Antagonists in Atrial Fibrillation Patients on Chronic Hemodialysis: A Systematic Review and Meta-Analysis;Cardiology in Review;2024-07-11
4. Safety and efficacy of apixaban versus vitamin K antagonists in patients undergoing dialysis: a systematic review and meta-analysis;Renal Failure;2024-05-21
5. Meta‐analysis evaluating apixaban in patients with atrial fibrillation and end‐stage renal disease requiring dialysis;Journal of Arrhythmia;2024-05-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3